BCL2 and diabetic kidney disease: Additionally, up-regulation of Nrf2 down-regulated TNF-α, IL-6, Bax and p38 levels, suppressed NF-κB activation and increased Bcl-2 expression, showing anti-inflammatory and anti-apoptotic effects, conducive to preventing the STZ-induced DKD [41].